Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CRITICAL MINERALS GROUP LIMITED Proxy Solicitation & Information Statement 2024

Mar 27, 2024

64668_rns_2024-03-27_fcca8ee8-ebc1-4161-a862-9352bc361d86.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

ASX Announcement 28 March 2024

==> picture [390 x 117] intentionally omitted <==

General Meeting

Critical Minerals Group Limited (ASX: CMG) ( CMG or Company ) provides the following documents regarding its General Meeting to be held on Friday, the 3[rd] of May 2024 at 11am AEST:

  • Notice of General Meeting

  • Sample proxy form

Shareholders will be able to access the Notice on the Company’s website at:

https://www.criticalmineralsgroup.com.au/.

This announcement has been authorised for release by the board.

For more information, please contact:

Adam Gallagher

Company Secretary

[email protected]

(07) 5555 5077

Critical Minerals Group Limited | ACN 652 994 726 | Level 4, Gold Tower, 10 Eagle Street, Brisbane QLD 4000 [email protected] | (07) 5555 5077 | www.criticalmineralsgroup.com.au

==> picture [390 x 117] intentionally omitted <==

Critical Minerals Group Limited ACN 652 994 726 (Company)

NOTICE OF GENERAL MEETING AND EXPLANATORY STATEMENT

Notice is given that the General Meeting of the Company will be held as follows: Time : 11:00am (AEST)

Date : Friday, 3 May 2024

Place : To be held in person at: Level 4, Gold Tower, 10 Eagle Street, Brisbane, QLD, 4000

The Notice of General Meeting and Explanatory Statement is an important document and should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting.

Should you wish to discuss the matters on this Notice of General Meeting please do not hesitate to contact the Company Secretary on 07 5555 5077 or via email at [email protected].

Critical Minerals Group Limited | ACN 652 994 726 | Level 4, Gold Tower, 10 Eagle Street, Brisbane QLD 4000 [email protected] | (07) 5555 5077 | www.criticalmineralsgroup.com.au

Critical Minerals Group Limited

ACN 652 994 726

(Company)

CHAIRMAN’S LETTER TO SHAREHOLDERS

Dear Shareholder

I have the pleasure of inviting you to a General Meeting ( Meeting ) of Critical Minerals Group Limited ACN 652 994 726 ( Company ).

The Meeting of the Company’s shareholders ( Shareholders ) will be held at Level 4, Gold Tower, 10 Eagle Street, Brisbane, QLD, 4000 at 11.00am on Friday, 3 May 2024. This will be an in-person meeting only, and there will be no opportunity to join online.

Even if you plan to attend in person, you are encouraged to submit a directed proxy before the Meeting in accordance with the instructions in this notice of meeting.

Your vote is important and we also welcome your questions and comments at or prior to the Meeting.

Yours sincerely

Alan Broome AM Chairman

Chairman’s Letter

3

Critical Minerals Group Limited

ACN 652 994 726

(Company)

NOTICE OF MEETING

Notice is given that a General Meeting ( Meeting ) of the shareholders of the Company will be held as follows:

Time : 11:00am

Date : Friday, 3 May 2024

Place : To be held in person at:

Level 4, Gold Tower, 10 Eagle Street, Brisbane, QLD, 4000

In accordance with section 110D of the Corporations Act 2001 (Cth) ( Corporations Act ), the Company will not be sending hard copies of the Notice of Meeting ( Notice ) unless a Shareholder has elected to receive documents in hard copy in accordance with the Corporations Act.

Shareholders can access the Notice on the Company’s website at https://www.criticalmineralsgroup.com.au/. The Notice and a blank Proxy Form have also been released on the ASX Market Announcements Platform.

The Explanatory Statement to this Notice provides additional information on matters to be considered at the Meeting. The Explanatory Statement and the Proxy Form form part of this Notice.

Terms and abbreviations used in this Notice and Explanatory Statement are defined in the Glossary (Section 5).

Notice of Meeting

4

AGENDA

1. Resolution 1 – Ratification for issue of Placement Shares

To consider and, if thought fit, pass the following Resolution, with or without amendment, as an Ordinary Resolution:

“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders grant approval for and ratify the prior issue of 3,276,000 Shares in the Company at an issue price of $0.15 ( Placement Shares ) issued on 18 March 2024 to certain sophisticated and professional investors on the terms as set out in the Explanatory Statement.”

Voting exclusion statement pursuant to Listing Rule 7.5.8 – Resolution 1

The Company will disregard any votes cast in favour of Resolution 1 by or on behalf of a person that participated in, or who will obtain a material benefit as a result of, the issue of the Placement Shares or any of their associates.

However, this does not apply to a vote cast in favour of Resolution 1 by:

  • A person as proxy or attorney for a person who is entitled to vote on Resolution 1 in accordance with directions given to the proxy or attorney to vote on Resolution 1 in that way; or

  • The Chairman of the Meeting as proxy or attorney for a person who is entitled to vote on Resolution 1, in accordance with a direction given to the Chairman of the Meeting to vote on that resolution as the Chairman of the Meeting decides; or

  • A holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • The beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on Resolution 1; and

  • The holder votes on that resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

Voting Intentions of the Chairman

Shareholders should be aware that any undirected proxies given to the Chairman will be cast by the Chairman and counted in favour of Resolutions 1, subject to compliance with the Corporations Act. In exceptional circumstances, the Chairman of the Meeting may change his voting intention on any Resolution, in which case an ASX announcement will be made.

Further details, in relation to the ability of the Chairman to vote on undirected proxies are set out in the accompanying proxy form.

2. Resolution 2 – Approval to issue Shares to a Substantial Holder (Idemitsu Australia Pty Ltd)

To consider and, if thought fit, pass the following as an ordinary resolution of the Company:

“That, for the purposes of Listing Rule 10.11.2 and for all other purposes, Shareholders grant approval for the issue of up to 3,649,333 Shares to Idemitsu Australia Pty Ltd ACN 010 236 272 or its nominee at an issue price of $0.15 ( Substantial Holder Shares ) on the terms as set out in the Explanatory Statement.”

Voting exclusion statement pursuant to Listing Rule 10.11 – Resolution 2

The Company will disregard any votes cast on Resolution 2 by:

• Idemitsu Australia Pty Ltd ACN 010 236 272 (or its nominee); and • An associate of Idemitsu Australia Pty Ltd ACN 010 236 272 (or its nominee).

Notice of Meeting

5

However, this does not apply to a vote cast in favour of Resolution 2 by:

  • A person as proxy or attorney for a person who is entitled to vote on Resolution 2 in accordance with directions given to the proxy or attorney to vote on Resolution 2 in that way; or

  • The Chairman of the Meeting as proxy or attorney for a person who is entitled to vote on Resolution 2, in accordance with a direction given to the Chairman of the Meeting to vote on that resolution as the Chairman of the Meeting decides; or

  • A holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

  • The beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on Resolution 2; and

  • The holder votes on that resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

Voting Intentions of the Chairman

Shareholders should be aware that any undirected proxies given to the Chairman will be cast by the Chairman and counted in favour of Resolutions 2, subject to compliance with the Corporations Act. In exceptional circumstances, the Chairman of the Meeting may change his voting intention on any Resolution, in which case an ASX announcement will be made.

Further details, in relation to the ability of the Chairman to vote on undirected proxies are set out in the accompanying proxy form.

GENERAL BUSINESS

To consider any other business as may be lawfully put forward in accordance with the Constitution of the Company.

BY ORDER OF THE BOARD

Adam Gallagher

Company Secretary Dated: 28 March 2024

Notice of Meeting

6

Critical Minerals Group Limited ACN 652 994 726

EXPLANATORY STATEMENT

1. Introduction

This Explanatory Statement has been prepared for the information of Shareholders of the Company in connection with the business to be conducted at the Meeting to be held by in person at:

Level 4, Gold Tower, 10 Eagle Street, Brisbane, QLD, 4000

on Friday, 3 May 2024 commencing at 11:00am (AEST).

This Explanatory Statement should be read in conjunction with and forms part of the accompanying Notice. The purpose of this Explanatory Statement is to provide information to Shareholders in deciding whether or not to pass the Resolutions in the Notice. A Proxy Form is located at the end of the Explanatory Statement.

2. Information for Shareholders

==> picture [14 x 9] intentionally omitted <==

Eligibility to vote

The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that persons eligible to vote at the Meeting are those who are registered as Shareholders at 7:00pm (AEST) on 1 May 2024.

Each of the Resolutions will be decided by poll.

==> picture [16 x 10] intentionally omitted <==

Venue and Voting Information

The Meeting of the Shareholders to which this Notice relates will be held at 11:00am (AEST) on Friday, 3 May 2024 at Level 4, Gold Tower, 10 Eagle Street, Brisbane, QLD, 4000.

Shareholders are also encouraged to submit questions before the Meeting to the Company.

Questions submitted before the Meeting must be sent in writing to the Company Secretary at [email protected] at least 5 Business Days before the Meeting.

The Chair of the Meeting will also allow time for Shareholders to ask questions during the Meeting regarding the formal business.

The business of the Meeting affects your shareholding, and your vote is important.

==> picture [16 x 9] intentionally omitted <==

Voting in person

To vote in person, attend the Meeting on the date and at the place set out above.

Should it become necessary or appropriate to make alternative arrangements for the holding or conduct of the Meeting, an announcement will be made on the Company’s website and through the ASX Market Announcement Platform.

==> picture [16 x 10] intentionally omitted <==

Voting by proxy

To vote by proxy, please use one of the following methods:

Online Lodge the Proxy Form online at https://investor.automic.com.au/#/loginsah by following the instructions: Login to the Automic website using the holding details as shown on the Proxy Form. Click on “ View Meetings ” – “ Vote ”. To use the online lodgement facility,

7

Shareholders will need their holder number (Securityholder Reference Number (SRN) or
Holder Identification Number (HIN)) as shown on the front of the Proxy Form.
By
post
Automic, GPO Box 5193, Sydney NSW 2001
By
hand
Automic, Level 5, 126 Phillip Street, Sydney NSW 2000
By
email
Completing the enclosed Proxy Form and emailing it to:
[email protected]

Your proxy instruction must be received not later than 48 hours before the commencement of the Meeting ( Proxy Deadline ). Proxy Forms received later than this time will be invalid.

==> picture [16 x 10] intentionally omitted <==

Proxies

Shareholders who are entitled to vote at the Meeting have a right to appoint a proxy to attend the Meeting and vote on their behalf. The proxy need not be a Shareholder of the Company and may be an individual or body corporate. If a Shareholder is entitled to cast two or more votes, they may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the proxy appointments do not specify a proportion or number, each proxy may exercise half of the Shareholder’s votes.

All Shareholders are invited and encouraged to participate in the Meeting and are encouraged to lodge a directed Proxy Form to the Company in accordance with the instructions noted in the Proxy Form. Lodgement of a Proxy Form will not preclude a Shareholder from attending and voting at the Meeting.

Even if you plan to attend in person, you are encouraged to submit a Proxy Form before the Meeting so that your vote can be counted if, for any unforeseen reason, you cannot attend.

==> picture [16 x 10] intentionally omitted <==

Power of Attorney

If the Proxy Form is signed under a power of attorney on behalf of a Shareholder, the attorney must ensure that either the original power of attorney or a certified copy is sent with the Proxy Form, unless the power of attorney has already provided it to the Share Registry.

==> picture [16 x 10] intentionally omitted <==

Corporate representatives

If a representative of a corporate Shareholder or a corporate proxy will be attending the Meeting, the representative should bring to the Meeting adequate evidence of their appointment, unless this has previously been provided to the Share Registry.

Where a Shareholder is a body corporate, the Shareholder may appoint a person to act as its representative to attend the Meeting by providing that person with:

  • (a) A letter or certificate authorising him or her as the corporation’s representative, executed in accordance with the corporation’s constitution; or

  • (b) A copy of the resolution appointing the representative, certified by a secretary or director of the corporation.

==> picture [16 x 9] intentionally omitted <==

Directing your proxy how to vote

You can direct your proxy how to vote on a particular Resolution by marking the appropriate box on the Proxy Form.

If you mark the abstain box for a particular Resolution, you are directing your proxy not to vote on that item.

If you do not mark any particular Resolution and no direction is given, you are appointing your proxy to vote as he or she decides, subject to any voting exclusions that may apply to the proxy.

8

If you appoint a proxy, you may still attend the Meeting. However, your proxy’s rights to speak and vote will be suspended while you are present.

==> picture [16 x 10] intentionally omitted <==

Chair of the Meeting appointed proxy

A Shareholder may appoint the Chair of the Meeting as proxy. The Chair of the Meeting will be deemed to be the Shareholder’s proxy if the Shareholder submits the Proxy Form but does not name a proxy or if the person appointed as proxy does not attend the Meeting or does not vote on a poll in accordance with the Shareholder’s directions.

If the Shareholder provides a voting direction on a particular Resolution, the Chair of the Meeting must vote in accordance with the direction on a poll.

==> picture [21 x 10] intentionally omitted <==

Voting on Resolutions

All voting on the Resolutions proposed and stated in the Notice will be by way of a poll and not a show of hands. The results of the Poll will not be announced during Meeting. The poll results will be confirmed following the end of the Meeting and announced to the ASX as soon as they are available.

3. Resolution 1 – Ratification for issue of Placement Shares

==> picture [14 x 10] intentionally omitted <==

Background

On 7 March 2024, the Company announced that it had received firm commitments to raise $1.7m from a placement of Shares in the Company at a price of $0.15 per Share ( Placement Shares ) to sophisticated and professional investors and a Substantial Holder ( Placement ). Of the Placement Shares issued, 7,684,000 have been issued to unrelated professional and sophisticated investors ( Unrelated Investors ), and 3,649,333 will be issued to a Substantial Holder subject to shareholder approval of Resolution 2.

Resolution 1 is an ordinary resolution seeking Shareholder approval under Listing Rule 7.4 for the ratification of the prior issue of 3,276,000 Placement Shares issued under Listing Rule 7.1 to Unrelated Investors.

==> picture [16 x 10] intentionally omitted <==

Listing Rule 7.1

Under Listing Rule 7.1, the Company is generally not permitted to issue more than 15% of its issued share capital in any 12 month period unless the issue is approved by the Company’s shareholders or an exemption applies ( 15% Capacity ).

At the Company’s last Annual General Meeting on 8 November 2023, shareholders approved and gave the Company authority to issue an additional 10% of its issued share capital under Listing Rule 7.1A without the issue being approved by the Company’s shareholders ( Additional Capacity ). As such, prior to the Placement occurring, the Company was permitted to issue 25% of its issued share capital (less the securities issued in the preceding 12 months that had not been subsequently approved in accordance with listing rule 7.4) without the issue being approved by the Company’s shareholders ( Combined Capacity ). As part of the Placement Shares, the Company issued 3,276,000 Shares under its available 15% capacity under listing rule 7.1 and 4,408,000 Shares under its available 10% capacity under listing rule 7.1A. The details of the balance of the Placement (being 3,649,333 Shares) are set out under Resolution 2.

As the Placement does not fit within any of the exceptions to Listing Rule 7.1, the issue of the Placement Shares has reduced the Company’s Combined Capacity for the next 12 months, such that the Company can only issue its remaining capacity of 3,336,000 without Shareholder approval under Listing Rule 7.1.

The Additional Capacity was fully utilised under the Placement and cannot be reinstated until the earlier of:

  • a) the date that is 12 months after the date of the 2023 annual general meeting that was held on 8 November 2023;

  • b) the time and date of the Company’s next annual general meeting; or

  • c) the time and date of the approval by Shareholders of a transaction under Listing Rule 11.1.2 (a significant change to the nature or scale of activities) or 11.2 (disposal of main undertaking),

9

or such longer period if allowed by ASX.

==> picture [16 x 10] intentionally omitted <==

Listing Rule 7.4

Under Listing Rule 7.4, an issue of any securities made without approval under Listing Rule 7.1 may be treated as having been made with approval under Listing Rule 7.1 if each of the following apply:

  • (a) the issue was not in breach of that rule; and

  • (b) the holders of ordinary shares in the Company subsequently approve the issue.

Although Shareholder approval was not required for the Company to issue the Placement Shares (as they were issued under the Company’s Combined Capacity discussed above), the Company wishes to retain as much flexibility as possible to issue additional Equity Securities in the future without having to obtain Shareholder approval for such issues, as required under Listing Rule 7.1.

Accordingly, the Company is seeking ratification by Shareholders of the prior issue of the Placement Shares issued under listing rule 7.1 under this Resolution 1, pursuant to Listing Rule 7.4.

Approval of Resolution 1 will refresh the Company’s ability, to the extent of the Placement Shares issued under Listing Rule 7.1, to issue further capital during the next 12 months under Listing Rule 7.1 (if required) without the need to obtain further Shareholder approval, therefore providing the Company with greater flexibility in managing its future capital requirements.

==> picture [16 x 9] intentionally omitted <==

Effect of Shareholder Approval

If Resolution 1 is passed, the Placement Shares issued under Listing Rule 7.1 will be excluded in calculating the Company’s utilisation of its 15% Capacity under Listing Rule 7.1, which will provide the Company flexibility to issue Shares and Options in the future without obtaining Shareholder approval, if required.

If Resolution 1 is not passed, the Placement Shares issued under Listing Rule 7.1 will be included in calculating the Company’s utilisation of its 15% Capacity under Listing Rule 7.1, effectively decreasing the number of equity securities it can issue without shareholder approval over the 12 month period following the issue date which will impact on the Company’s flexibility for future capital raisings.

The passing of Resolution 1 will not affect the Company’s Additional Capacity under Listing Rule 7.1A which has been fully utilised.

==> picture [16 x 10] intentionally omitted <==

Requirements of Listing Rule 7.5

Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in relation to Resolution 1:

Name of the persons
receiving the securities
7.5.1
The Placement Shares, the subject of Resolution 1, have been issued
and allotted to unrelated sophisticated and professional investors that fall
within one or more of the classes of exemptions specified in section 708
of the Corporations Act determined by the Board and the Lead Manager
(Unrelated Investors). The Unrelated Investors were identified through a
bookbuild process which involved the Company seeking expressions of
interest to participate in the capital raising from non-related parties of the
Company
A Substantial Holder of the Company will also participate in the
Placement, subject to shareholder approval of Resolution 2.
Vested Equities Pty Ltd ACN 601 621 390 (Lead Manager) was
appointed as the sole lead manager to the Placement. The Lead
Manager is entitled to receive:

Management fee: 2% (excluding GST) on all funds raised in the
Placement; and

Selling fee: 4% (excluding GST) on funds introduced by Vested

10

Equities.

Ongoing Investor Relations fee: $30,000 (excluding GST) over a
6 month period for ongoing investor relations support.
Number and class of
securities
7.5.2
The total number of securities issued under the Placement to Unrelated
Investors was 7,684,000 fully paid ordinary shares, of which 3,276,000
were issued under Listing Rule 7.1.
If not fully paid ordinary
securities, a summary of
material terms
7.5.3
The Placement Shares were issued on terms identical to the Company’s
existing quoted Shares.
Date of issue
7.5.4
The Placement Shares were issued on 18 March 2024.
Issue Price
7.5.5
The Placement Shares were issued at a price of $0.15 per Share.
The purpose of the issue
7.5.6
Funds raised under the issue of the Placement Shares (less fees and
expenses) are intended to be used for background ecology and water
studies; feasibility study (PFS, BFS); development of electrolyte
manufacturing strategy and corporate overheads.
Summary of material terms of
the relevant agreement
7.5.7
The Placement Shares were issued pursuant to customary placement
documentation by the Lead Manager
Voting exclusion statement
7.5.8
A voting exclusion statement is set out under Resolution 1 of the Notice.

==> picture [16 x 9] intentionally omitted <==

Directors’ Recommendation

All of the Directors unanimously recommend that Shareholders vote in favour of Resolution 1, for the reasons set out above.

4. Resolution 2 – Approval to issue Shares to a Substantial Holder (Idemitsu Australia Pty Ltd)

==> picture [14 x 10] intentionally omitted <==

General

Resolution 2 seeks Shareholder approval for the issue of up to 3,649,333 Shares to Idemitsu Australia Pty Ltd ACN 010 236 272 or its nominee ( Idemitsu ), a Substantial Holder of the Company, under the Placement. The participation in the Placement by Idemitsu will be on the same terms as the Placement made to Unrelated Investors.

Resolution 2 seeks Shareholder approval for the proposed issue of Shares to Idemitsu under Listing Rule 10.11.

Further details regarding the Placement Shares are set out in section 3.1.

==> picture [16 x 9] intentionally omitted <==

Listing Rule 10.11

Listing Rule 10.11 provides that, subject to certain exceptions set out in Listing Rule 10.12, a listed company must not issue, or agree to issue, equity securities to, inter alia, a related party, without shareholder approval.

As Idemitsu is a 30%+ holder in the Company ( Substantial Holder ), the proposed issue of Shares under the Placement falls within Listing Rule 10.11.2. It is the view of the Company that the exceptions set out in Listing Rule 10.12 do not apply to the current circumstances. Accordingly, Shareholder approval is sought for the issue

11

of the Placement Shares pursuant to Listing Rule 10.11.

If Resolution 2 is approved, the Company will be able to proceed with the issue to Idemitsu of up to 3,649,333 shares on the terms set out below.

Further, as a separate shareholder approval under Listing Rule 7.1 is not required for issues of securities that have received shareholder approval under Listing Rule 10.11, the grant of Shares to Idemitsu will not be included in the Company’s 15% placement capacity for the purposes of Listing Rule 7.1, provided that the issue is completed within one month of the date of the Meeting.

Idemitsu is viewed by the Company as a strategic holder. Idemitsu has been operating in Australia for over 40 years, as a subsidiary of Japanese company Idemitsu Kosan Co. Ltd and has publicly committed to playing a proactive role in diversifying Australia’s energy portfolio through mining, retail fuels, agriculture, and renewable initiatives. Idemitsu has agreed to subscribe for up to the number of Shares under the Placement that will see its current percentage holding of the Company maintained on a post-raise basis, which is 3,649,333 Shares.

If Resolution 2 is not approved by shareholders, the Company will not be able to issue Shares to Idemitsu under the Placement and will not receive the associated consideration.

==> picture [16 x 10] intentionally omitted <==

Prescribed information pursuant to Listing Rule 10.11

The following information is provided for the purposes of the shareholder approval sought under Listing Rule 10.11, and in accordance with the requirements of Listing Rule 10.13 in respect of the proposed issue of shares:

Name of the persons
receiving the securities
10.13.1
The Placement Shares will be issued to Idemitsu Australia Pty Ltd
ACN 010 236 272 (or its nominee).
Category under Listing Rule
10.11
10.13.2
Idemitsu is a related party of the Company under Listing Rule 10.11.2, as
it is a Substantial Holder in the Company.
Number and class of
securities
10.13.3
The maximum number of Placement Shares to be issued to Idemitsu is
3,649,333.
The Placement Shares to be issued under Resolution 2 are fully paid
ordinary class shares and will rank equally in all respects with the
Company’s existing Shares on issue.
Summary of material terms
10.13.4
The Placement Shares will be fully paid, ordinary shares.
Date of Issue
10.13.5
If Resolution 2 is approved, the Company will issue the Shares in a single
tranche immediately following the Meeting and in any event not later than
1 month of the Meeting (or such later date as permitted by ASX).
Issue Price
10.13.6
The Shares will be issued at an issue price of $0.15 per Share, being the
same as the Placement Shares the subject of Resolution 1.
Purpose
10.13.7
Funds raised from the issue of the Shares (less fees and expenses) are
intended to be used for background ecology and water studies; feasibility
study (PFS, BFS); development of electrolyte manufacturing strategy;
and tenements and corporate overheads.
Whether the issue is intended
to remunerate or incentivise
10.13.8
The Placement Shares to be issued to Idemitsu are not being issued in
connection with remuneration or as an incentive.

12

Summary of material terms of
agreement
10.13.9
The Placement Shares will be issued pursuant to customary placement
documentation by the Lead Manager.
Voting exclusion statement
10.13.10
A voting exclusion statement in respect of Resolution 2 are set out above
in the Notice.

==> picture [16 x 9] intentionally omitted <==

Directors’ Recommendation

Mr. Steven Kovac is a director of the Company and the Chief Executive Officer of Idemitsu. Given his executive role in Idemitsu Mr. Kovac has chosen to abstain from making a recommendation regarding Resolution 2. Mr. Kovac and his related parties do not hold any securities in the Company.

Each of the Directors, aside from Mr. Steven Kovac who abstains, recommends that Shareholders vote in favour of Resolution 2, for the reasons set out above.

5. GLOSSARY

Term Meaning
$ Australian dollars.
Additional 10% Capacity has the meaning given to that term in in sectionError! Reference source
not found.of the Explanatory Statement.
AEST Australian Eastern Standard Time, being the time in Brisbane, Queensland.
Associate has the meaning given in sections 12 and 16 of the Corporations Act.
Section 12 is to be applied as if paragraph 12(1)(a) included a reference to
the ASX Listing Rules and on the basis that the Company is the “designated
body” for the purposes of that section. A related party of a director or officer
of the Company or of a Child Entity of the Company is to be taken to be an
associate of the director or officer unless the contrary is established.
ASX ASX Limited ACN 008 624 691 and, where the context permits, the
Australian Securities Exchange operated by ASX.
ASX Listing Rules the listing rules of ASX, as amended from time to time.
ASX Principles the ASX Corporate Governance Principles and Recommendations (4th
edition).
Automic The Company’s Share Registry provider Automic Pty Ltd
Board the board of Directors of the Company.
Business Day A.
for determining when a notice, consent or other communication is
given, a day that is not a Saturday, Sunday or public holiday in the
place to which the notice, consent or other communication is sent;
and
B.
for any other purpose, a day (other than a Saturday, Sunday or public
holiday) on which banks are open for general banking business in
Brisbane, Queensland.

13

Chair the person appointed to chair the Meeting convened by this Notice.
Company Critical Minerals Group Limited ACN 652 994 726.
Constitution the constitution of the Company as at the date of this Explanatory Statement.
Corporations Act the_Corporations Act 2001_(Cth).
Director a director of the Company.
Equity Securities has the same meaning as in the ASX Listing Rules.
Explanatory Statement means the explanatory statement accompanying this Notice.
General Meeting, GMorMeeting means the General Meeting of the Company to be held on Friday, 3 May
2024.
Lead Manager means Vested Equities Pty Ltd ACN 601 621 390.
Listing Rule means a listing rule of the ASX.
Meeting has the meaning in the introductory paragraph of the Notice.
Notice the notice of meeting attached to this Explanatory Statement.
Ordinary Resolution means a resolution passed by more than 50% of the votes cast by members
entitled to vote on the Resolution.
Placement means the placement of 7,684,000 Shares to Unrelated Investors and
3,649,333 Shares to Idemitsu, a Substantial Holder.
Placement Shares means the Shares issued to Unrelated Investors and a Substantial Holder,
in connection with the Placement, at a price of $0.15 per Share, first
announced by the Company on 7 March 2024.
Proxy Deadline has the meaning in section 2.4 of the Explanatory Statement.
Proxy Form the proxy form attached to this Notice.
Related Party has the meaning set out in the ASX Listing Rule 10.11.
Resolution a resolution set out in the Notice.
Substantial Holder means a holder in the Company’s Shares with at least 30% of the total
issued Shares in the Company for the purposes of ASX Listing Rule 10.11.2
Substantial Holder Shares means the 3,649,333 Shares to be issued to Idemitsu Australia Pty Ltd ACN
010 236 272 in connection with the Placement, at a price of $0.15 per Share.
Share being a fully paid ordinary share in the Company.
Share Registry being Automic Pty Ltd.
Shareholders means the shareholders of the Company.
Trading Day means a day determined by ASX to be a trading day in accordance with the
ASX Listing Rules.
Unrelated Investors means those unrelated sophisticated and professional investors who
participated in the Placement.

14

VWAP

means the volume weighted average price.

15

Proxy Voting Form If you are attending the Meeting in person, please bring this with you for Securityholder registration.

==> picture [135 x 58] intentionally omitted <==

Critical Minerals Group Limited | ABN 91 652 994 726

Your proxy voting instruction must be received by 11.00am (AEST) on Wednesday, 01 May 2024 , being not later than 48 hours before the commencement of the Meeting. Any Proxy Voting instructions received after that time will not be valid for the scheduled Meeting.

SUBMIT YOUR PROXY

SUBMIT YOUR PROXY
Complete the form overleaf in accordance with the instructions set out below.
YOUR NAME AND ADDRESS
The name and address shown above is as it appears on the Company’s share register. If this information is
incorrect, and you have an Issuer Sponsored holding, you can update your address through the investor
portal:https://investor.automic.com.au/#/homeShareholders sponsored by a broker should advise their
broker of any changes.
STEP 1 – APPOINT A PROXY
If you wish to appoint someone other than the Chair of the Meeting as your proxy, please write the name of
that Individual or body corporate. A proxy need not be a Shareholder of the Company. Otherwise if you
leave this box blank, the Chair of the Meeting will be appointed as your proxy by default.
DEFAULT TO THE CHAIR OF THE MEETING
Any directed proxies that are not voted on a poll at the Meeting will default to the Chair of the Meeting,
who is required to vote these proxies as directed. Any undirected proxies that default to the Chair of the
Meeting will be voted according to the instructions set out in this Proxy Voting Form , including where the
Resolutions are connected directly or indirectly with the remuneration of KMP.
STEP 2 - VOTES ON ITEMS OF BUSINESS
You may direct your proxy how to vote by marking one of the boxes opposite each item of business. All
your shares will be voted in accordance with such a direction unless you indicate only a portion of voting
rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the
appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may
vote as he or she chooses. If you mark more than one box on an item your vote on that item will be invalid.
APPOINTMENT OF SECOND PROXY
You may appoint up to two proxies. If you appoint two proxies, you should complete two separate Proxy
Voting Forms and specify the percentage or number each proxy may exercise. If you do not specify a
percentage or number, each proxy may exercise half the votes. You must return both Proxy Voting Forms
together. If you require an additional Proxy Voting Form, contact Automic Registry Services.
SIGNING INSTRUCTIONS
Individual:Where the holding is in one name, the Shareholder must sign.
Joint holding:Where the holding is in more than one name, all Shareholders should sign.
Power of attorney:If you have not already lodged the power of attorney with the registry, please attach a
certified photocopy of the power of attorney to this Proxy Voting Form when you return it.
Companies:To be signed in accordance with your Constitution. Please sign in the appropriate box which
indicates the office held by you.
Email Address:Please provide your email address in the space provided.
By providing your email address, you elect to receive all communications despatched by the Company
electronically (where legally permissible) such as a Notice of Meeting, Proxy Voting Form and Annual
Report via email.
CORPORATE REPRESENTATIVES
If a representative of the corporation is to attend the Meeting the appropriate ‘Appointment of Corporate
Representative’ should be produced prior to admission. A form may be obtained from the Company’s share
registry online at https://automic.com.au.
Lodging your Proxy Voting Form:
Online
Use your computer or smartphone to
appoint a proxy at
https://investor.automic.com.au/#/loginsahor
scan the QR code below using your
smartphone
Login & Click on ‘Meetings’. Use the
Holder Number as shown at the top of
this Proxy Voting Form.
BY MAIL:
Automic
GPO Box 5193
Sydney NSW 2001
IN PERSON:
Automic
Level 5, 126 Phillip Street
Sydney NSW 2000
BY EMAIL:
[email protected]
BY FACSIMILE:
+61 2 8583 3040
All enquiries to Automic:
WEBSITE:
https://automicgroup.com.au/
PHONE:
1300 288 664 (Within Australia)
+61 2 9698 5414 (Overseas)

STEP 1 - How to vote

APPOINT A PROXY:

I/We being a Shareholder entitled to attend and vote at the General Meeting of Critical Minerals Group Limited, to be held at 11.00am (AEST) on Friday, 03 May 2024 at Level 4, Gold Tower, 10 Eagle Street, Brisbane, QLD, 4000 hereby:

==> picture [37 x 172] intentionally omitted <==

Appoint the Chair of the Meeting (Chair) OR if you are not appointing the Chair of the Meeting as your proxy, please write in the box provided below the name of the person or body corporate you are appointing as your proxy or failing the person so named or, if no person is named, the Chair, or the Chair’s nominee, to vote in accordance with the following directions, or, if no directions have been given, and subject to the relevant laws as the proxy sees fit and at any adjournment thereof. The Chair intends to vote undirected proxies in favour of all Resolutions in which the Chair is entitled to vote. Unless indicated otherwise by ticking the “for”,” against” or “abstain” box you will be authorising the Chair to vote in accordance with the Chair’s voting intention.

STEP 2 - Your voting direction

Resolutions For Against
Abstain
Against
Abstain
1
Ratification for issue of Placement Shares
2
Approval to issue Shares to a Substantial Holder (Idemitsu Australia Pty Ltd)
Please note:If you mark the abstain box for a particular Resolution, you are directing your proxy not to vote on that Resolution on a show of hands or on
a poll and your votes will not be counted in computing the required majority on a poll.
STEP 3 STEP 3 STEP 3 – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details – Signatures and contact details
Individual or Securityholder 1 Securityholder 2 Securityholder 3
Sole Director and Sole Company Secretary Director Director / Company Secretary
Contact Name:
Email Address:
Contact Daytime Telephone Date (DD/MM/YY)
/ /
By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible).